Business Law
Business Law News ISSUE 3, 2025, WINTER 2025
Content
- Ai In the Boardroom: a Forward-looking Legal Analysis of Board Meeting Management With Ai Agents
- Business Law News Editorial Team
- Duties Owed To Client Affiliates and Other Constituents
- Executive Committee of the Business Law Section 2025-2026
- From Deal To Dispute: Why Contract Clarity Matters
- Inside This Issue
- Letter From Co-chairs
- Letter From the Editor
- Susan H. Mac Cormac Receives Business Law Section's 2025 Roland E. Brandel Lifetime Achievement Award
- Table of Contents
- Recent Developments In the Purdue Pharma Case
RECENT DEVELOPMENTS IN THE PURDUE PHARMA CASE
Written by Leonard L. Gumport*
SUMMARY
In 2019, the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court") granted a preliminary injunction (the "Preliminary Injunction") that temporarily stayed creditors of chapter 11 debtors Purdue Pharma L.P. ("Purdue") and its affiliates (collectively, the "Debtors") from pursuing disputed claims against certain Sackler family members (the "Sacklers").
In 2020, in Dunaway v. Purdue Pharm. L.P.01, the United States District Court for the Southern District of New York (the "District Court") ("Dunaway") affirmed the Preliminary Injunction and its first extension by the Bankruptcy Court. From 2020-2025, the Bankruptcy Court incrementally extended the duration of the Preliminary Injunction.